INFINITY PHARMACEUTICALS, INC. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Infinity Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q2 2023.
  • Infinity Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending June 30, 2023 was -$10.1M, a 15.8% increase year-over-year.
  • Infinity Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending June 30, 2023 was -$42M, a 9.92% increase year-over-year.
  • Infinity Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$44.8M, a 0.53% increase from 2021.
  • Infinity Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$45.1M, a 17.1% decline from 2020.
  • Infinity Pharmaceuticals, Inc. annual Operating Income (Loss) for 2020 was -$38.5M, a 15.7% increase from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 -$42M -$10.1M +$1.9M +15.8% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 -$43.9M -$11.5M +$900K +7.25% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-09
Q4 2022 -$44.8M -$9.54M +$1.96M +17.1% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-28
Q3 2022 -$46.8M -$10.9M -$131K -1.22% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 -$46.7M -$12M -$767K -6.82% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$45.9M -$12.4M -$825K -7.12% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$45.1M -$11.5M -$1.27M -12.4% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-28
Q3 2021 -$43.8M -$10.8M -$1.91M -21.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$41.9M -$11.3M -$2.33M -26.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$39.6M -$11.6M -$1.08M -10.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 -$38.5M -$10.2M +$1.32M +11.4% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-29
Q3 2020 -$39.8M -$8.85M +$1.74M +16.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 -$41.6M -$8.92M +$826K +8.48% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-27
Q1 2020 -$42.4M -$10.5M +$3.28M +23.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 -$45.7M -$11.6M -$3.1M -36.6% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-16
Q3 2019 -$42.6M -$10.6M -$23.8M -180% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$18.8M -$9.75M -$2.61M -36.6% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-30
Q1 2019 -$16.2M -$13.8M -$4.27M -44.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$11.9M -$8.46M -$436K -5.44% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-03
Q3 2018 -$11.5M $13.2M +$21M Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-30
Q2 2018 -$32.5M -$7.14M +$2.97M +29.4% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-30
Q1 2018 -$35.5M -$9.52M +$959K +9.15% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 -$36.4M -$8.02M +$15.2M +65.5% Oct 1, 2017 Dec 31, 2017 10-K 2018-03-15
Q3 2017 -$51.7M -$7.84M +$12.1M +60.7% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-05
Q2 2017 -$63.7M -$10.1M -$63.2M -119% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 -$599K -$10.5M +$30.3M +74.3% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 -$30.9M -$23.2M +$15.9M +40.7% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-15
Q3 2016 -$46.8M -$19.9M -$63.2M -146% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-15
Q2 2016 $16.4M $53M +$91.6M Apr 1, 2016 Jun 30, 2016 10-K 2018-03-15
Q1 2016 -$75.3M -$40.8M +$51.8M +56% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-15
Q4 2015 -$127M -$39.2M -$53K -0.14% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-14
Q3 2015 -$127M $43.3M -$64.4M -59.8% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-14
Q2 2015 -$62.6M -$38.6M -$3.37M -9.57% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-14
Q1 2015 -$59.2M -$92.6M -$51.3M -124% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-14
Q4 2014 -$7.92M -$39.1M -$6.02M -18.2% Oct 1, 2014 Dec 31, 2014 10-K 2016-02-23
Q3 2014 -$1.9M $108M +$142M Jul 1, 2014 Sep 30, 2014 10-K 2016-02-23
Q2 2014 -$144M -$35.2M -$2.47M -7.53% Apr 1, 2014 Jun 30, 2014 10-K 2016-02-23
Q1 2014 -$141M -$41.3M -$13.6M -49.3% Jan 1, 2014 Mar 31, 2014 10-K 2016-02-23
Q4 2013 -$128M -$33.1M +$14M +29.8% Oct 1, 2013 Dec 31, 2013 10-K 2015-02-24
Q3 2013 -$142M -$34.2M -$52.9M -282% Jul 1, 2013 Sep 30, 2013 10-K 2015-02-24
Q2 2013 -$88.8M -$32.8M -$18.5M -129% Apr 1, 2013 Jun 30, 2013 10-K 2015-02-24
Q1 2013 -$70.3M -$27.7M -$17.5M -172% Jan 1, 2013 Mar 31, 2013 10-K 2015-02-24
Q4 2012 -$52.8M -$47.1M -$33.5M -246% Oct 1, 2012 Dec 31, 2012 10-K 2014-02-25
Q3 2012 -$19.3M $18.8M +$30.3M Jul 1, 2012 Sep 30, 2012 10-K 2014-02-25
Q2 2012 -$49.6M -$14.3M -$2.92M -25.7% Apr 1, 2012 Jun 30, 2012 10-K 2014-02-25
Q1 2012 -$46.7M -$10.2M -$8.19M -417% Jan 1, 2012 Mar 31, 2012 10-K 2014-02-25
Q4 2011 -$38.5M -$13.6M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-05
Q3 2011 -$11.6M +$9.67M +45.5% Jul 1, 2011 Sep 30, 2011 10-K 2013-03-05
Q2 2011 -$11.4M -$5.83M -105% Apr 1, 2011 Jun 30, 2011 10-K 2013-03-05
Q1 2011 -$1.97M Jan 1, 2011 Mar 31, 2011 10-K 2013-03-05
Q3 2010 -$21.3M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-08
Q2 2010 -$5.53M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.